Lab Manager | Run Your Lab Like a Business
Challenging Host Cell Protein Assays

Challenging Host Cell Protein Assays

FAQs about improving risk mitigation by challenging host cell protein assays


Cytiva is a 3.3 billion USD global life sciences leader with nearly 7,000 employees across 40 sites dedicated to advancing and accelerating therapeutics. As a trusted partner to customers that...

ViewFull Profile.
Learn about ourEditorial Policies.

One of the major challenges of producing a generic anti-host-cell-protein (HCP) antibody is achieving enough coverage in a broad range of sample types. Almost every bioprocess is unique in some way, which means that the subpopulation of HCP present can also be unique.

Download this FAQ to learn about challenging your current HCP risk management strategy, courtesy of Cytiva.